About Contact Us Careers
Sign In

Liquid Biopsy Market - Top Companies and Manufacturers

  • Report ID: 69
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Global Liquid Biopsy Market TOC

  1. Market Definition
    1. Market Definition
    2. Market Segmentation
    3. Product Overview
  2. Research Methodology
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. End-users
    3. Secondary research
    4. Market size estimation
  3. Executive Summary- Global Liquid Biopsy Market
  4. Analysis of Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  5. Regulatory & Standards Landscape
  6. Pricing Analysis
  7. Epidemiology Analysis
  8. Impact of COVID-19 on the Liquid Biopsy Market
    1. Pre-COVID-19 Scenario, 2017-19
    2. COVID-19 scenario, 2020
    3. Post-COVID-19 scenario
  9. Comparative Analysis (Liquid biopsy vs Tissue-based biopsy)
  10. End-User Usability Analysis
  11. Competitive Structure
  12. Global Liquid Biopsy Market Outlook
    1. Global Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
        1.                           Tools, 2019-2028F (USD Million)
          1. Next generation sequencing (NGS), 2019-2028F (USD Million)
          2. Polymerase chain reaction (PCR), 2019-2028F (USD Million)
          3. Microarrays, 2019-2028F (USD Million)
        2. Assay kits & reagents, 2019-2028F (USD Million)
        3. Services, 2019-2028F (USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
        1. Circulating Tumor Cells, 2019-2028F (USD Million)
        2. Circulating Tumor DNA, 2019-2028F (USD Million)
        3. Exosomes, 2019-2028F (USD Million)
        4. Circulating RNA & Proteins, 2019-2028F (USD Million)
        5. Nucleosomes, 2019-2028F (USD Million)
      3. By Sample, 2019-2028F (in USD Million)
        1. Blood, 2019-2028F (USD Million)
        2. Urine, 2019-2028F (USD Million)
        3. Others, 2019-2028F (USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
        1. Early Disease Screening, 2019-2028F (USD Million)
        2. Therapy Selection, 2019-2028F (USD Million)
        3. Treatment Response Monitoring, 2019-2028F (USD Million)
        4. Molecular Health Monitoring, 2019-2028F (USD Million)
        5. Others, 2019-2028F (USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
        1. Lung Cancer, 2019-2028F (USD Million)
        2. Colorectal Cancer, 2019-2028F (USD Million)
        3. Breast Cancer, 2019-2028F (USD Million)
        4. Prostate Cancer, 2019-2028F (USD Million)
        5. Liver Cancer, 2019-2028F (USD Million)
        6. Head & Neck Cancer, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      6. By End-User, 2019-2028F (in USD Million)
        1. Hospitals, 2019-2028F (USD Million)
        2. Clinics, 2019-2028F (USD Million)
        3. Research Laboratories, 2019-2028F (USD Million)
        4. Academic Institutes, 2019-2028F (USD Million)
        5. Others, 2019-2028F (USD Million)
      7. By Region, 2019-2028F (in USD Million)
        1. North America, 2019-2028F (in USD Million)
        2. Europe, 2019-2028F (in USD Million)
        3. Asia Pacific, 2019-2028F (in USD Million)
        4. Latin America, 2019-2028F (in USD Million)
        5. Middle East & Africa, 2019-2028F (in USD Million)
  13. North America Liquid Biopsy Market Outlook
    1. North America Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  14. Latin America Liquid Biopsy Market Outlook
    1. Latin America Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  15. Europe Liquid Biopsy Market Outlook
    1. Europe Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  16. Asia Pacific Liquid Biopsy Market Outlook
    1. Asia Pacific Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  17. Middle East & Africa Liquid Biopsy Market Outlook
    1. Middle East & Africa Liquid Biopsy Market Segmentation Analysis 2019-2028
      1. By Product, 2019-2028F (in USD Million)
      2. By Biomarker Type, 2019-2028F (in USD Million)
      3. By Sample, 2019-2028F (in USD Million)
      4. By Clinical Application, 2019-2028F (in USD Million)
      5. By Disease Indication, 2019-2028F (in USD Million)
      6. By End-User, 2019-2028F (in USD Million)
      7. By Country, 2019-2028F (in USD Million)
  18. Competitive Structure
    1. Qiagen
    2. F. Hoffmann-La Roche Ltd
    3. Bio-Rad Laboratories, Inc.
    4. Illumina, Inc.
    5. Inivata Limited
    6. Agena Bioscience, Inc.
    7. Thermo Fisher Scientific
    8. Guardant Health, Inc.

Companies Dominating the Liquid Biopsy Landscape

    • Qiagen
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Inivata Limited
    • Agena Bioscience, Inc.
    • Thermo Fisher Scientific
    • Guardant Health, Inc
Browse Key Market Insights with Data Illustration:

In the News

  • In February 2021, Thermo Fisher Scientific Inc. announced that it had acquired the point-of-care molecular diagnostic company, Mesa Biotech, Inc. The deal would allow Thermo Fisher to ring much needed diagnostics to the market.
  • In June 2020, Inivata Limited announced that their strategic partner NeoGenomics, Inc., in the United States, has launched InVisionFirst-Lung liquid biopsy commercially. The test is FDA-approved and covers all National Comprehensive Cancer Network (NCCN) guidelines. The launch of the test would also allow the company in expanding its geographical presence and promoting its products in other countries.
  • In March 2019, Guardant Health, Inc. announced that it would acquire Bellwether Bio, Inc. and the transaction is projected to close by April 2019. The acquisition would help Guardant Health to enhance their product pipeline in the future.

Author Credits:  Radhika Pawar


  • Report ID: 69
  • Published Date: Oct 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing incidence of cancer and, rising research and development activities are the major factors responsible for the growth of the market.

The market is anticipated to attain a CAGR of 30.7% over the forecast period i.e., 2020-2028.

High regulatory standards associated with biopsy procedures is estimated to act as barriers to the market growth.

Asia Pacific is estimated to create notable growth opportunities for market growth over the forecast period.

The major players in the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc. and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample